PROVECTUS BIOPHARMACEUTICALS, INC.
Shares Outstanding
| Fiscal Year | Shares Outstanding |
|---|---|
| FY2020 | 398.8M |
| FY2021 | 408.2M |
| FY2022 | 419.5M |
| FY2023 | 419.5M |
| FY2024 | 419.8M |
Shares Outstanding
| Fiscal Year | Shares Outstanding |
|---|---|
| FY2020 | 398.8M |
| FY2021 | 408.2M |
| FY2022 | 419.5M |
| FY2023 | 419.5M |
| FY2024 | 419.8M |